WO2002023200A3 - Human breast cancer biomarkers - Google Patents

Human breast cancer biomarkers Download PDF

Info

Publication number
WO2002023200A3
WO2002023200A3 PCT/US2001/028133 US0128133W WO0223200A3 WO 2002023200 A3 WO2002023200 A3 WO 2002023200A3 US 0128133 W US0128133 W US 0128133W WO 0223200 A3 WO0223200 A3 WO 0223200A3
Authority
WO
WIPO (PCT)
Prior art keywords
breast cancer
human breast
cancer biomarkers
markers
biomarkers
Prior art date
Application number
PCT/US2001/028133
Other languages
French (fr)
Other versions
WO2002023200A2 (en
Inventor
Tai-Tung Yip
Thang T Pham
Christine Yip
Norton Kitagawa
Tina Doede
Original Assignee
Ciphergen Biosystems Inc
Tai-Tung Yip
Thang T Pham
Christine Yip
Norton Kitagawa
Tina Doede
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc, Tai-Tung Yip, Thang T Pham, Christine Yip, Norton Kitagawa, Tina Doede filed Critical Ciphergen Biosystems Inc
Priority to AU2001288921A priority Critical patent/AU2001288921A1/en
Publication of WO2002023200A2 publication Critical patent/WO2002023200A2/en
Publication of WO2002023200A3 publication Critical patent/WO2002023200A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Abstract

The invention provides markers, methods and kits that can be used as an aid for breast cancer diagnosis using markers that are differentially present in the samples of breast cancer patients and a control (e.g., women in whom breast cancer is undetectable).
PCT/US2001/028133 2000-09-11 2001-09-07 Human breast cancer biomarkers WO2002023200A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288921A AU2001288921A1 (en) 2000-09-11 2001-09-07 Human breast cancer biomarkers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23179200P 2000-09-11 2000-09-11
US60/231,792 2000-09-11

Publications (2)

Publication Number Publication Date
WO2002023200A2 WO2002023200A2 (en) 2002-03-21
WO2002023200A3 true WO2002023200A3 (en) 2003-02-27

Family

ID=22870662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/028133 WO2002023200A2 (en) 2000-09-11 2001-09-07 Human breast cancer biomarkers

Country Status (2)

Country Link
AU (1) AU2001288921A1 (en)
WO (1) WO2002023200A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855554B2 (en) 2001-09-21 2005-02-15 Board Of Regents, The University Of Texas Systems Methods and compositions for detection of breast cancer
EP1639365A1 (en) * 2003-05-15 2006-03-29 Europroteome AG Differential diagnosis of colorectal cancer and other diseases of the colon
EP1477803A1 (en) * 2003-05-15 2004-11-17 Europroteome AG Serum protein profiling for the diagnosis of epithelial cancers
EP1673623A1 (en) * 2003-05-15 2006-06-28 Europroteome AG Methods and applications of biomarker profiles in the diagnosis and treatment of breast cancer
CA2524708C (en) 2003-06-06 2009-10-06 F. Hoffmann-La Roche Ag Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer
CN1813190B (en) * 2003-07-02 2011-06-29 佳能株式会社 Information acquisition method
CA2537662A1 (en) 2003-10-15 2005-05-06 F. Hoffmann-La Roche Ag Use of protein asc as a marker for breast cancer
DK1882946T3 (en) 2003-12-23 2010-05-31 Hoffmann La Roche Method for Assessing Rheumatoid Arthritis by Measuring Anti-CCP and Interleukin 6
EP2401621B1 (en) 2009-02-24 2013-08-14 Roche Diagnostics GmbH Use of s-erbb-3 as a marker for cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BERGMAN A C ET AL: "IDENTIFICATION OF GEL-SEPARATED TUMOR MARKER PROTEINS BY MASS SPECTROMETRY", ELECTROPHORESIS, WEINHEIM, DE, vol. 21, no. 3, February 2000 (2000-02-01), pages 679 - 686, XP000923086, ISSN: 0173-0835 *
CHONG BATHSHEBA E ET AL: "Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.", RAPID COMMUNICATIONS IN MASS SPECTROMETRY, vol. 12, no. 24, 1998, pages 1986 - 1993, XP001039848, ISSN: 0951-4198 *
CHONG BATHSHEBA E ET AL: "Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis.", RAPID COMMUNICATIONS IN MASS SPECTROMETRY, vol. 13, no. 18, 1999, pages 1808 - 1812, XP001006015, ISSN: 0951-4198 *
PAWELETZ C P ET AL: "RAPID PROTEIN DISPLAY PROFILING OF CANCER PROGRESSION DIRECTLY FROM HUMAN TISSUE USING A PROTEIN BIOCHIP", DRUG DEVELOPMENT RESEARCH, NEW YORK, NY, US, vol. 49, no. 1, 2000, pages 34 - 42, XP001001234, ISSN: 0272-4391 *

Also Published As

Publication number Publication date
WO2002023200A2 (en) 2002-03-21
AU2001288921A1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
AU4085097A (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
DE69907151D1 (en) CANCER TREATMENT
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
ATE296839T1 (en) ANTIBODIES FOR CANCER TREATMENT AND DIAGNOSIS
AU7868300A (en) Prostate cancer marker proteins
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU4927501A (en) Prostate cancer markers
WO2002023200A3 (en) Human breast cancer biomarkers
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2005070456A3 (en) Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
WO2003058198A3 (en) Human breast cancer biomarkers
WO2001042792A3 (en) Diagnosis of cervical cancer using marker proteins
WO2003031942A8 (en) Reagents and methods useful for detecting diseases of the breast
WO2001092877A3 (en) Method of identifying and/or isolating stem cells
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
WO2002027329A3 (en) Biomarkers of transitional cell carcinoma of the bladder
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
AU2002306568A1 (en) Forms of prostate specific antigens and methods for their detection
AU2001257313A1 (en) Method and apparatus for the detection and diagnosis of cancer, specifically breast cancer using diffusion mri
AU2002348101A1 (en) Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP